Literature DB >> 14675580

Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.

Philip M Mottram1, Rodel Leano, Thomas H Marwick.   

Abstract

B-type natriuretic peptide (BNP) levels increase in systolic heart failure (HF). However, the value of BNP in hypertensive patients with suspected diastolic HF (symptoms suggestive of HF but normal ejection fraction) and its relation to myocardial function in these patients is unclear. We prospectively studied 72 ambulatory hypertensive subjects (40 women, mean age 58 +/- 8 years) with exertional dyspnea and ejection fraction > or =50%. Diastolic function was evaluated with transmitral and pulmonary venous Doppler, mitral annular velocities (pulsed-wave tissue Doppler), and flow propagation velocity (color M-mode). Systolic function was assessed with strain and strain rate derived from color tissue Doppler imaging. BNP was related to myocardial function and the presence or absence of global diastolic dysfunction. By conventional Doppler criteria, 34 patients had normal left ventricular diastolic function and 38 had isolated diastolic dysfunction. BNP values were higher in patients with diastolic dysfunction (46 +/- 48 vs 20 +/- 20 pg/ml, p=0.004) and were related independently to blood pressure, systolic strain rate, left atrial function (p<0.01 for all), and age (p=0.015). Patients with diastolic dysfunction and pseudonormal filling had higher BNP levels compared with impaired relaxation (89 +/- 47 vs 35 +/- 42 pg/ml, p=0.001). However, 79% of patients with diastolic dysfunction had BNP levels within the normal range. We conclude that in ambulatory hypertensive patients with symptoms suggestive of mild HF and normal ejection fraction, BNP is related to atrial and ventricular systolic parameters, blood pressure, and age. Although elevated in the presence of diastolic dysfunction, the BNP level mostly is in the normal range and, therefore, has limited diagnostic value in stable patients with suspected diastolic HF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675580     DOI: 10.1016/j.amjcard.2003.08.053

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction.

Authors:  Charles A Nelson; Colin Case; Jane McCrohon; Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

2.  Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.

Authors:  Imran Uraizee; Susan Cheng; Chung-Lieh Hung; Anil Verma; James D Thomas; Michael R Zile; Gerard P Aurigemma; Scott D Solomon
Journal:  Am J Hypertens       Date:  2013-06-22       Impact factor: 2.689

3.  Isolated diastolic dysfunction--diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide.

Authors:  S Hettwer; B Panzner-Grote; R Witthaut; K Werdan
Journal:  Clin Res Cardiol       Date:  2007-09-20       Impact factor: 5.460

Review 4.  Heart failure: hemodynamic assessment using echocardiography.

Authors:  James N Kirkpatrick; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2008-05       Impact factor: 2.931

5.  The relationship between tissue Doppler imaging and seric NTproBNP levels in sinus rhythm patients: a prospective study.

Authors:  Cristian Mornos; Adina Ionac; Dragos Cozma; Dan Rusinaru; Daniela Maximov; Lucian Petrescu; Alina Lupu; Stefan-Iosif Dragulescu
Journal:  Int J Cardiovasc Imaging       Date:  2007-10-31       Impact factor: 2.357

6.  The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.

Authors:  Ceyhun Ceyhan; Selim Unal; Cigdem Yenisey; Tarkan Tekten; F Banu Ozturk Ceyhan
Journal:  Int J Cardiovasc Imaging       Date:  2007-08-09       Impact factor: 2.357

7.  Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.

Authors:  Mingqiang Fu; Jingmin Zhou; Juying Qian; Xuejuan Jin; Hongmin Zhu; Chunlin Zhong; Michael Fu; Yunzeng Zou; Junbo Ge
Journal:  Lipids Health Dis       Date:  2012-08-30       Impact factor: 3.876

8.  Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction.

Authors:  Claus Luers; Rolf Wachter; Sibylle Kleta; Marc Uhlir; Janka Koschack; Martin Scherer; Lutz Binder; Christoph Herrmann-Lingen; Antonia Zapf; Bettina Kulle; Michael M Kochen; Burkert Pieske
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

9.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11

10.  Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction.

Authors:  Vinicio A de Jesus Perez; Francois Haddad; Roham T Zamanian
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.